Development of a new instrument for examination of stiffness in the breast using haptic sensor technology

Sensors and Actuators, A: Physical

Volumn 143, Issue 2, 2008, Pages 430-438

  Murayama, Yoshinobu ^a   Haruta, Mineyuki ^a   Hatakeyama, Yuichi ^b   Shiina, Takayuki ^a   Sakuma, Hiroshi ^b   Takenoshita, Seichi ^b   Omata, Sadao ^a   Constantinou, Christos E ^c  

^a NIHON UNIVERSITY   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Haptic visualization; Tactile sensor; Tumor stiffness; Virtual reality

Indexed keywords

CHEMOTHERAPY; PROBES; SENSOR ARRAYS;

HAPTIC SENSOR TECHNOLOGY; NEOADJUVANT CHEMOTHERAPY;

CHEMICAL SENSORS;

EID: 41349121773     PISSN: 09244247     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sna.2007.11.035     Document Type: Article

References (19)

1. Cancer Trends Progress Report-2005 Update, National Cancer Institute, NIH, DHHS, Bethesda, MD, December, 2005, http://progressreport.cancer.gov.
2. Omata S., and Terunuma Y. New tactile sensor like the human hand and its applications. Sens. Actuators A 3 (1992) 9-15
3. Omata S., Murayama Y., and Constantinou C.E. Real time robotic tactile sensor system for the determination of the physical properties of biomaterials. Sens. Actuator A 112 2-3 (2004) 278-285
4. Omata S., and Constantinou C.E. Modeling of micturition characteristics based on prostatic stiffness modulation using hormones and adrenergic antagonists. Trans. IEEE Biomed. Eng. 42 (1995) 843-848
5. Murayama Y., Constantinou C.E., and Omata S. Development of tactile mapping system suitable for the characterization of tissue engineering materials using novel tactile sensing technology. Sens. Actuator A 120 (2005) 543-549
6. Fisher B., Bryant J., Wolmark N., et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J. Clin. Oncol. 16 (1998) 2672-2685
7. Wolmark N., Wang J., Mamounas J., Bryant E., and Fisher B. Preoperative chemotherapy in patients with operable breast cancer. Nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J. Natl. Cancer Inst. 30 (2001) 96-102
8. Van der Hage J.A., van de Velde C.J., Julien J.P., et al. Preoperative chemotherapy in primary operable breast cancer. Results from the European Organization for Research and Treatment of Cancer trial 10902. J. Clin. Oncol. 19 (2001) 4224-4237
9. Bear H.D., Anderson S., Brown A., et al. The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide. Preliminary results from the National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J. Clin. Oncol. 21 (2003) 4165-4174
10. Fisher B., Brown A., Mamounas E., et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer. Findings from National Surgical Adjuvant Breast and Bowel Project B-18. J. Clin. Oncol. 15 (1997) 2483-2493
11. Jacquillat C., Weil M., Baillet F., et al. Results of neoadjuvant chemotherapy and radiation therapy in breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer. Cancer 66 (1990) 119-129
12. Bonadonna G., Veronesi I., Brambilla C., et al. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J. Natl. Cancer Inst. 82 (1990) 1539-1545
13. Kleesattel C., and Gladwell G.M.L. The contact-impedance meter-1. Ultrasonics (1968) 175-180
14. Krouskop T.A., Wheeler T.M., Kallel F., Garra B.S., and Hall T. Elastic moduli of breast can prostate tissues under compression. Ultrason. Imaging 20 (1998) 260-274
15. Herrada J., Iyer R.B., and Atkinson E.N. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. Clin. Cancer Res. 3 (1997) 1565-1569
16. Helvie M.A., Joynt L.K., Cody R.L., et al. Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy. Radiology 198 (1996) 327-332
17. Chagpar A.B., Middleton L.P., Sahin A.A., et al. Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic size in patients treated with neoadjuvant chemotherapy. Ann. Surg. 243 (2006) 257-264
18. Londero V., Bazzocchi M., Del Frate C., et al. Locally advanced breast cancer: comparison of mammography, sonography and MRI imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur. Radiol. 14 (2004) 1371-1379
19. Goldhirsch A., Wood W., Gelber R., Coates A., Thurlimann B., Senn H.J., and Members P. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann. Oncol. 18 (2007) 1133-1144